From October 1, 2023 to January 1, 2024, the company has repurchased 3,014,355 shares, representing 5.93% for $30.43 million. With this, the company has completed the repurchase of 31,414,836 shares, representing 49.07% for $325 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.46 USD | +0.96% | +3.50% | -15.84% |
Apr. 12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
Apr. 12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.84% | 455M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.